To further examine the relationship between TREM1 expression and the therapy-predictive power of the immune subclasses, we stratified patients first according to subclass (FID, WID or PID), and then according to low or high TREM1 expression (Figure 1A). The gene discussed is TREM1; the disease is pelvic inflammatory disease.